-
公开(公告)号:US20240342175A1
公开(公告)日:2024-10-17
申请号:US18617800
申请日:2024-03-27
申请人: Howard Mitz
发明人: Howard Mitz
IPC分类号: A61K31/517 , A61K31/16 , A61K31/167 , A61K31/192 , A61K31/22 , A61K31/352 , A61K31/381 , A61K31/40 , A61K31/401 , A61K31/428 , A61K31/437 , A61K31/44 , A61K31/4409 , A61K31/4439 , A61K31/472 , A61K31/506 , A61K31/5377 , A61K31/541 , A61K31/551 , A61K31/65 , A61K35/60 , A61K36/00 , A61K38/57 , A61P25/00
CPC分类号: A61K31/517 , A61K31/16 , A61K31/167 , A61K31/192 , A61K31/22 , A61K31/352 , A61K31/381 , A61K31/40 , A61K31/401 , A61K31/428 , A61K31/437 , A61K31/44 , A61K31/4409 , A61K31/4439 , A61K31/472 , A61K31/506 , A61K31/5377 , A61K31/541 , A61K31/551 , A61K31/65 , A61K35/60 , A61K36/00 , A61K38/57 , A61P25/00
摘要: The present invention provides methods and compositions for treating synaptic dysfunction and spinal cord injuries comprising, for example, the administration of a compound that increases the level of PZP in vivo.
-
公开(公告)号:US12016950B2
公开(公告)日:2024-06-25
申请号:US17379804
申请日:2021-07-19
申请人: Try This First, Inc.
发明人: Scott Morehouse
IPC分类号: A61K31/355 , A23G3/56 , A61B17/24 , A61K9/00 , A61K31/045 , A61K31/047 , A61K31/07 , A61K31/167 , A61K31/19 , A61K31/192 , A61K31/194 , A61K31/197 , A61K31/375 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/616 , A61K31/675 , A61K31/7032 , A61K33/00 , A61K33/06 , A61K36/00 , A61K36/28 , A61K36/48 , A61K36/534 , A61K36/63 , A61K36/71 , A61K36/752 , A61K36/808 , A61K45/06
CPC分类号: A61K9/0056 , A23G3/563 , A61B17/24 , A61K31/045 , A61K31/047 , A61K31/07 , A61K31/167 , A61K31/19 , A61K31/192 , A61K31/194 , A61K31/197 , A61K31/355 , A61K31/375 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/616 , A61K31/675 , A61K31/7032 , A61K33/00 , A61K33/06 , A61K36/00 , A61K36/28 , A61K36/48 , A61K36/534 , A61K36/63 , A61K36/71 , A61K36/752 , A61K36/808 , A61K45/06
摘要: The present invention relates generally to a methods and apparatuses for treating ear pain and clearing excess fluid from Eustachian tubes.
-
公开(公告)号:US11882837B2
公开(公告)日:2024-01-30
申请号:US16577944
申请日:2019-09-20
申请人: SOGANG UNIVERSITY RESEARCH & BUSINESS DEVELOPMENT FOUNDATION , KOREA FOOD & DRUG ADMINISTRATION
发明人: Kyu-Ho Lee , Hyo-Sun Kwak , Youchul Jung , Kyung Jo Lee , Jeong-A Kim , Boram Jang , Sebin Kang
IPC分类号: A01N63/10 , A61L2/00 , A01N1/00 , A01N63/20 , A61K35/66 , A61K35/74 , A61K36/00 , A61P31/04 , C12N1/20 , C12P39/00 , C12R1/01 , C12R1/025 , C12N1/00
CPC分类号: A01N63/10 , A01N1/00 , A01N63/20 , A61K35/66 , A61K35/74 , A61K36/00 , A61L2/00 , C12N1/20 , C12N1/205 , C12P39/00 , A61P31/04 , C12N1/00 , C12R2001/01 , C12R2001/025
摘要: Provided is a novel bacterial strain Bacteroides vulgatus MGM001 (Bacteroides vulgatus MGM001) and its use. The LPS from the strain of the subject matter has cytotoxicity weaker than the conventional ones and shows synergistic effect on the inhibition of biofilm formation when used in combination with LTA.
-
公开(公告)号:US11844763B2
公开(公告)日:2023-12-19
申请号:US17663065
申请日:2022-05-12
发明人: Gary J. Speier
IPC分类号: A61K36/185 , A61K9/00 , A61K9/70 , A61K31/352 , A61K36/00
CPC分类号: A61K36/185 , A61K9/006 , A61K9/7023 , A61K31/352 , A61K36/00 , A61K2236/37
摘要: The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.
-
公开(公告)号:US11666530B2
公开(公告)日:2023-06-06
申请号:US16998514
申请日:2020-08-20
发明人: Philippe Ragot , Esther Pons , Bernard Mompon , Cedric Rousseau
IPC分类号: A61K9/00 , A23F3/22 , A23F3/34 , A23F5/28 , A23F3/38 , A23F5/36 , A23F3/30 , A23G1/30 , A23G1/00 , A23L33/21 , A23L27/10 , A23L33/105 , A23P20/00 , A61K36/185 , A61K36/48 , A61K36/53 , A61K36/534 , A61K36/54 , A61K36/74 , A61K36/82 , A61K36/00
CPC分类号: A61K9/0056 , A23F3/22 , A23F3/30 , A23F3/34 , A23F3/385 , A23F5/28 , A23F5/36 , A23G1/002 , A23G1/30 , A23L27/10 , A23L33/105 , A23L33/21 , A23P20/00 , A61K36/185 , A61K36/48 , A61K36/53 , A61K36/534 , A61K36/54 , A61K36/74 , A61K36/82 , A61K36/00
摘要: The present invention relates to an edible product, which comprises a fibrous plant product and a plant extract applied thereto. Further, the invention relates to a corresponding method for producing said edible product and its use in at least one of food, food supplement, medicinal, cosmetic, well-being, nutraceutical or phytotherapeutical applications. The plants used may be all plants comprising one or more substances of interest for an edible product.
-
公开(公告)号:US20190230973A1
公开(公告)日:2019-08-01
申请号:US16148462
申请日:2018-10-01
申请人: Jordan Seth Rubin , GRV Fund, LLC
发明人: Jordan Seth Rubin
IPC分类号: A23P10/30 , A61K36/00 , A23L11/00 , A23L2/38 , C12N1/20 , A23L33/135 , A61K35/747 , A61K35/742
CPC分类号: A23P10/30 , A23L2/382 , A23L11/09 , A23L33/135 , A23Y2220/67 , A61K35/742 , A61K35/747 , A61K36/00 , C12N1/20
摘要: The present invention is an improved probiotic nutritional supplement, in unit dosage form for animal or human consumption, and a method of preparing it. Bacteria, such as but not limited to Bacillus subtilis, are cultured in connection with, for example, a legume, aloe vera juice or other fruit or vegetable juice, turmeric, green tea or one of many other media constituents that probiotic bacteria have not been cultured on or with previously, for the purpose of preparing unit dosage forms thereof.
-
公开(公告)号:US20190015403A1
公开(公告)日:2019-01-17
申请号:US16132440
申请日:2018-09-16
发明人: Xavier Mulet , Gregory Yu Foo Szto , David Kannar
IPC分类号: A61K31/455 , A61K31/201 , A61K9/20 , A61K45/06 , A61K9/00 , A61K31/22 , A61K36/00 , A61K9/107
CPC分类号: A61K31/455 , A61K9/006 , A61K9/1075 , A61K9/20 , A61K31/201 , A61K31/22 , A61K36/00 , A61K45/06 , A61K2300/00
摘要: The present invention provides a composition including an amphiphilic compound capable of self-assembling into a liquid crystalline phase; and a niacin compound. In another aspect, the present invention provides a method for the treatment of a disease state comprising administering a therapeutically effective amount of a pharmaceutical composition incorporating that composition
-
公开(公告)号:US20180242627A1
公开(公告)日:2018-08-30
申请号:US15965960
申请日:2018-04-29
发明人: John Gillespie
IPC分类号: A23L33/15 , A61K45/06 , A61K31/522 , A23L33/16 , A61K35/12 , A61K33/42 , A61K33/34 , A61K33/32 , A61K33/30 , A61K33/04 , A61K33/00 , A61K31/714 , A61K31/593 , A61K31/575 , A23L33/12 , A61K31/519 , A61K31/4415 , A61K31/375 , A61K31/355 , A61K31/202 , A61K31/197 , A61K31/122 , A61K31/07 , A23L33/00 , A23L23/00 , A61K36/00
CPC分类号: A23L33/15 , A23L23/00 , A23L33/12 , A23L33/16 , A23L33/40 , A23V2002/00 , A61K31/07 , A61K31/122 , A61K31/197 , A61K31/202 , A61K31/355 , A61K31/375 , A61K31/4415 , A61K31/519 , A61K31/522 , A61K31/575 , A61K31/593 , A61K31/714 , A61K33/00 , A61K33/04 , A61K33/26 , A61K33/30 , A61K33/32 , A61K33/34 , A61K33/42 , A61K35/12 , A61K36/00 , A61K45/06 , A61K2300/00 , A23V2200/322 , A23V2250/1588 , A23V2250/161 , A23V2250/1612 , A23V2250/1618 , A23V2250/1626 , A23V2250/1642 , A23V2250/1882 , A23V2250/2108 , A23V2250/702 , A23V2250/704 , A23V2250/708 , A23V2250/714
摘要: The present invention provides food products, nutritional programs, and methods for meeting nutritional needs of subjects with dementia and related cognitive disorders. In one embodiment, the invention provides a food product comprising a reversibly sealed container and a soup, wherein the soup is in the container and comprises a total volume of 200-2000 mls, a vegetable or meat component, 300 to 2500 calories, a macronutrient caloric distribution comprising: 20-80% fat, 10-45% protein, and 10-65% carbohydrate, about 2% to about 40% medium chain triglycerides, omega 3 fatty acids in an amount of 100 to 2000 mg and less than 20 solid food particles having a volume greater than about 20 cm3. Such food products, when administered to affected subjects, can positively impact (i) nutritional status; (ii) quality of life; (iii) disease course; (v) the demand for assistance from a care giver; (vi) subject compliance with a nutritional plan using the food product, and (vii) ease of monitoring compliance by the caregiver for verification.
-
公开(公告)号:US20180235868A1
公开(公告)日:2018-08-23
申请号:US15960589
申请日:2018-04-24
CPC分类号: A61K8/97 , A23K20/179 , A23L5/43 , A61K8/498 , A61K36/00 , A61K2800/10 , A61K2800/42 , A61Q90/00 , C09B61/00 , D06P1/34 , Y10T442/20
摘要: The invention provides a pigment composition comprising anthocyanic vacuolar inclusions or “AVIs” from a plant, and an acceptable carrier. The invention also provides methods for colouring products with the pigment composition, and products comprising the pigment composition or AVIs.
-
公开(公告)号:US20180206505A1
公开(公告)日:2018-07-26
申请号:US15928735
申请日:2018-03-22
发明人: Shanta M. Modak , Santoshkumar Hanmantrao Dongre , Lauserpina A. Caraos , Nayana Baiju , Hari Krishnan Ramachandran
IPC分类号: A01N65/44 , A01N31/04 , A61K36/15 , A61K36/899 , A61K36/355 , A61K36/31 , A61K36/886 , A61K36/752 , A61K31/12 , A61K31/045 , A61K31/047 , A23L3/3472 , A61K8/92 , A61Q19/10 , A61K36/185 , A61K36/81 , A61K36/76 , A61K36/28 , A01N65/22 , A61K36/00 , A61K8/97 , A61Q17/00 , A61K8/34 , A01N65/00 , A01N59/16 , A01N59/00 , A01N37/36 , A01N31/08 , A01N31/02 , A01N65/06 , A01N65/24 , A01N65/48 , A01N65/08 , A01N65/36
CPC分类号: A01N65/44 , A01N31/04 , A01N31/08 , A01N37/36 , A01N59/00 , A01N59/16 , A01N65/00 , A01N65/22 , A01N65/24 , A01N65/36 , A23L3/3472 , A61K8/34 , A61K8/922 , A61K8/97 , A61K31/045 , A61K31/047 , A61K31/12 , A61K36/00 , A61K36/15 , A61K36/185 , A61K36/28 , A61K36/31 , A61K36/355 , A61K36/752 , A61K36/76 , A61K36/81 , A61K36/886 , A61K36/899 , A61Q17/005 , A61Q19/10 , Y02A50/338 , Y02A50/339 , Y02A50/347 , A01N31/02 , A01N2300/00 , A61K2300/00 , A01N65/08 , A01N65/48 , A01N65/06
摘要: Disclosed are compositions comprising antimicrobially effective low concentrations of benzyl alcohol, one or more essential oil and one or more botanical extract. The compositions of the application may be used in personal care products including wound care products or in veterinary use. In certain embodiments, compositions are provided having antimicrobial active agents that are substantially or essentially entirely derived from natural sources, thereby allowing the user to avoid harsh and/or toxic chemicals. This may be particularly advantageous in products for use by or on children or pets or for use in households or other environments occupied by children or animals.
-
-
-
-
-
-
-
-
-